CCL22 and neoplasm: GBM tumor cells and associated myeloid populations produce immunomodulatory factors such as indoleamine 2,3-dioxygenase (IDO), CCL2, and CCL22, which contribute to the recruitment and regulation of T cell populations within the tumor microenvironment [74,75].